-ISO 9001:2000
   

Products

Our products are manufactured with the ultimate goal of delivering maximum possible benefits to the end user.

We achieved this through our constant support of innovative technologies, in manufacturing high quality and cutting edge products. The total field staff in domestic marketing is 1420.

   
- - -
-

The wide range of high quality and cutting edge products are marketed domestically through 5 different marketing divisions which are dedicated to specific therapeutic segment.

-
Marketing Divisions
Spektra
Aura
Altius
Hospitroy
  Novogen
Speciality Products
Orphan Drugs
Enoxaparin 40mg & 60mg Inj. Oral Transmucosal Fentanyl Citrate
 
A diverse portfolio of over 50 brands in the therapeutic areas of Pain management, Gynaecology, Nutraceuticals & Nutritional.
A premium cardiac division with the motto of "Concern for the Heart". Aura is known in the industry for its premium brands.
Altius is a multi-speciality division with "The Promise of Higher Satisfaction" through innovative technology products offering improved therapeutic benefits.
Troikaa's latest endeavour to serve the rapidly expanding hospital networks. With the motto of "Quality First", Hospitroy has a significant presence in institutional markets.
Novogen is the branded generic division. The objective is to help those patients who cannot afford expensive branded medicines.

 
Our Speciality products have distinct benefits over competitive products with the support of Novel Drug Delivery System (NDDS).
 
Overlooking the profit motive and to make India self sufficient, we manufacture several orphan drugs which do not have adequate market potential.
 
 
   
-

 
Corporate Philosophy
Troikaa Pharmaceuticals Limited is a young pharmaceutical company, which has acquired a reputation of an innovative company, over the years. We have been steadfastly sowing the basics of Innovation, Quality and Service to reap excellence.

Home | Company | Products | Technologies | International Business | Media Releases | Human Resources | Business Alliances | Research Publications

Copyright 2009 Troikaa Pharmaceuticals Ltd. - Disclaimer